It uses light to record and transmit brain signals and worked for a year with minimal scarring in mice.

Gene editors usually take years to test and perfect. KJ Muldoon’s treatment took only six months. Now his doctors want to go even faster.

Commercial-scale fusion edges closer with record plasma pressure.

If dazzling potential doesn’t translate quickly into steady, profitable demand, the excitement can slip away surprisingly fast.

From AI-powered race cars to a highly effective mRNA flu shot, check out this week's awesome tech stories from around the web.

Called 3D necroprinting, the sustainable system can print extremely intricate structures at high resolution.

The tiny chips hitch a ride on immune cells to target inflammation in the brain. Scientists hope to kick off clinical trials within three years.

We're living through a golden age of scientific capability. CRISPR can edit genes. Synthetic biology can program cells. Biomanufacturing can replace petrochemicals. The R&D breakthroughs are accelerating faster than ever with AI and robotics.

So why does…

We're living through a golden age of scientific capability. CRISPR can edit genes. Synthetic biology can program cells. Biomanufacturing can replace petrochemicals. The R&D breakthroughs are accelerating faster than ever with AI and robotics.

So why does…

A range of CRISPR gene therapies are taking aim at chronically high cholesterol, reducing the risk of heart disease.

Behavior can be deceptive. What matters for consciousness is not what you do, but how you do it.

Every week, we scour the web for important, insightful, and fascinating stories in science and technology.

There's a golden opportunity to avoid mistakes made here on Earth.

Months after the one-and-done treatment, a three-year-old boy with Hunter syndrome is thriving.

The new gene therapy focuses on a type of DNA error shared by a wide range of rare inherited conditions.

History says we can’t be too sure.

Every week, we scour the web for important, insightful, and fascinating stories in science and technology.

The vaccine stopped runaway allergic reactions for a year in mice. It could evolve into a blanket therapy for food allergies, from peanuts to shellfish.

GPT-4, Claude, and Llama sought out popular peers, connected with others via existing friends, and gravitated towards those similar to them.

The technology is still in its infancy. But its trajectory suggests that ethical conversations may become pressing far sooner than expected.

An immune tag-team promises to hold the virus in check for years—even without medication.